CHRS
Coherus Oncology, Inc. · Healthcare
Director Mats Wahlstrom sold $3.4M of Coherus Oncology, Inc.
Sold$3,430,020
$17.15Price
200,000Shares
−100%Stake
What CHRS did after the filing
Prices for CHRS after this filing aren't in yet.
Traded Wed, Jun 17. Filed Fri, Jun 19, 12:33 PM ET, during the session. Not investment advice.